"Anti angiogenic therapy" trang 1 - tải miễn phí từ tailieuXANH
A new anti-glioma therapy, AG119: Pre-clinical assessment in a mouse GL261 glioma model

A new anti-glioma therapy, AG119: Pre-clinical assessment in a mouse GL261 glioma model
8    57    0
A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis

A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis
7    67    0
Final results from IMPROVE: A randomized, controlled, open-label, two-arm, cross-over phase IV study to determine patients’ preference for everolimus in combination with exemestane or capecitabine in combination with bevacizumab in advanced HR-positive, HER2-negative breast cancer

Final results from IMPROVE: A randomized, controlled, open-label, two-arm, cross-over phase IV study to determine patients’ preference for everolimus in combination with exemestane or capecitabine in combination with bevacizumab in advanced HR-positive, HER2-negative breast cancer
12    62    0
Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patients

Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patients
10    44    0
Reducing tumor growth and angiogenesis using a triple therapy measured with Contrast-enhanced ultrasound (CEUS)

Reducing tumor growth and angiogenesis using a triple therapy measured with Contrast-enhanced ultrasound (CEUS)
11    48    0
Differential sensitivity of prostate tumor derived endothelial cells to sorafenib and sunitinib

Differential sensitivity of prostate tumor derived endothelial cells to sorafenib and sunitinib
13    46    0
Comparative effectiveness of approved first-line anti-angiogenic and molecularly targeted therapeutic agents in the treatment of good and intermediate risk metastatic clear cell renal cell carcinoma

Comparative effectiveness of approved first-line anti-angiogenic and molecularly targeted therapeutic agents in the treatment of good and intermediate risk metastatic clear cell renal cell carcinoma
9    70    0
Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: A hellenic cooperative oncology group clinical translational study

Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: A hellenic cooperative oncology group clinical translational study
12    53    0
Potential efficacy of weekly low-dose administration of bevacizumab as a combination therapy for platinum-resistant ovarian carcinoma: A retrospective analysis

Potential efficacy of weekly low-dose administration of bevacizumab as a combination therapy for platinum-resistant ovarian carcinoma: A retrospective analysis
7    19    1
Isoprenaline/β2-AR activates Plexin-A1/ VEGFR2 signals via VEGF secretion in gastric cancer cells to promote tumor angiogenesis

Isoprenaline/β2-AR activates Plexin-A1/ VEGFR2 signals via VEGF secretion in gastric cancer cells to promote tumor angiogenesis
15    61    0
Anti-angiogenic agents for the treatment of solid tumors: Potential pathways, therapy and current strategies – A review

Anti-angiogenic agents for the treatment of solid tumors: Potential pathways, therapy and current strategies – A review
15    44    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.